GPT and metabolic syndrome: Elevated serum ALT levels indicate a high specificity and a reasonable sensitivity for liver injury and are associated with an increased risk of liver-specific mortality as well as non-hepatic diseases such as type-2 diabetes mellitus, metabolic syndrome, cardiovascular diseases, and malignancies [45].